Clinical Hold For VaxGen's Anthrax Vaccine Could Lead To Termination Of HHS Contract
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA puts Phase II trial for investigational anthrax vaccine on hold due to stability concerns.